Cardurion Pharmaceuticals
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardi
Biotechnology
📍 Burlington, MA
Founded 2017
Current Valuation
$760M
as of 2024-Q3
PRIVATE
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
Company Profile
Last Round
Series B — $260M (Jul 2024)
Fundraising Status
Series B · $260M · 1y 11mo ago
privateTotal raised $603M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $260M | Jul 2024 | — | $760M |
BiotechnologyHealth CareMedicalPharmaceutical
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.